Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3239 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Sun Pharma’s benzonatate capsules

Benzonatate USP capsules are therapeutically equivalent to Forest Lab’s Tessalon, and are available in two strengths: capsules containing 100mg and 200mg benzonatate USP. Benzonatate is an antitussive, used

RxElite and Premier sign multi-source contract

RxElite was awarded this multi-source contract listing for all classes of trade and the company’s anesthetic gas products are immediately available to all Premier members. Sevoflurane is the

Synta’s Q4 losses rise

The company reported a net loss attributable to common stockholders of $122.1 million, or $3.76 per share for the year ended December 31, 2007, compared to $59.1 million

IDM Pharma’s Q4 revenues surge

Total revenues were $14.6 million for the year ended December 31, 2007, compared to total revenues of $11.3 million for the year ended December 31, 2006. Net loss

Humana to acquire OSF HealthPlans

The purchase of OSF HealthPlans, a subsidiary of OSF Saint Francis, is expected to increase Humana’s fully insured commercial membership by approximately 34,000, its self-insured business by approximately